Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

17.90
+0.70004.07%
Volume:354.25K
Turnover:6.15M
Market Cap:789.26M
PE:10.74
High:17.91
Open:17.28
Low:17.00
Close:17.20
52wk High:31.26
52wk Low:16.65
Shares:44.09M
Float Shares:32.84M
Volume Ratio:0.63
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.67
EPS(LYR):2.03
ROE:10.39%
ROA:5.34%
PB:1.02
PE(LYR):8.82

Loading ...

Jefferies Downgrades Amphastar Pharmaceuticals to Hold From Buy, Adjusts Price Target to $22 From $30

MT Newswires Live
·
Apr 21

Amphastar downgraded to Hold from Buy at Jefferies

TIPRANKS
·
Apr 21

Amphastar Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 14

Amphastar Pharmaceuticals Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Apr 08

Amphastar executives present at Needham Healthcare Conference webcast

Reuters
·
Apr 06

BRIEF-Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing

Reuters
·
Mar 16

Amphastar Pharmaceuticals Inc - Authorizes $50 Mln Increase to Share Buyback Program on March 12, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 16

Amphastar Pharmaceuticals publishes investor presentation outlining shift to proprietary and biosimilar drug pipeline mix at 85%

Reuters
·
Mar 11

BRIEF-Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing

Reuters
·
Mar 07

Amphastar Pharmaceuticals: on March 3, Co & Nanjing Hanxin Pharmaceutical Technology Entered Into Amendment to Contract Research Agreement

THOMSON REUTERS
·
Mar 07

Amphastar Pharmaceuticals Inc - Supply Agreement Effective for Five Years With Payments in Chinese Yuan - SEC Filing

THOMSON REUTERS
·
Mar 07

Amphastar Pharmaceuticals: Pursuant to Amendment, Co to Use Research Cell Banks That Hanxin Develops to Make Master Cell Banks for AMP-105

THOMSON REUTERS
·
Mar 07

Amphastar Signs New Executive Employment Agreements With Liawatidewi and Zhou

Reuters
·
Mar 07

Amphastar Nanjing Signs Five-Year Supply Agreement With Nanjing Letop Biotechnology

Reuters
·
Mar 07

Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks

TIPRANKS
·
Mar 06

Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narratives Despite Low 9.5x P/E

Simply Wall St.
·
Feb 28

Amphastar Pharmaceuticals Down Nearly 16%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Dow Jones
·
Feb 28

Stock Track | Amphastar Pharmaceuticals Plummets 15.29% Intraday on Earnings Miss and Analyst Target Price Cut

Stock Track
·
Feb 27

Stock Track | Amphastar Pharmaceuticals Plunges 14.68% in Pre-Market on Earnings Miss and Analyst Target Price Cut

Stock Track
·
Feb 27

Amphastar Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Feb 27